Terumo Co. (OTCMKTS:TRUMY) Short Interest Up 46.2% in April

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 3,800 shares, an increase of 46.2% from the March 31st total of 2,600 shares. Based on an average daily trading volume, of 137,800 shares, the short-interest ratio is currently 0.0 days.

Terumo Stock Performance

TRUMY traded down $0.02 on Friday, reaching $16.60. The company had a trading volume of 78,817 shares, compared to its average volume of 55,827. Terumo has a fifty-two week low of $12.56 and a fifty-two week high of $20.60. The stock has a market cap of $24.75 billion, a P/E ratio of 34.95 and a beta of 0.65. The company's fifty day moving average is $21.13 and its 200 day moving average is $17.67. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.13 and a current ratio of 1.90.

Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its earnings results on Wednesday, February 7th. The company reported $0.14 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.14. Terumo had a net margin of 11.14% and a return on equity of 8.26%. The firm had revenue of $1.62 billion for the quarter. As a group, analysts predict that Terumo will post 0.57 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.